Linkedin X-twitter Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Marketplace

Drug screening software, 9/13

AACC 2013 AB Sciex’s MPX TF 1.0 software is designed to accelerate drug screening, with accurate mass-based technology for laboratories performing clinical research. The software delivers faster turnaround times, increased sample throughput, and lower costs compared with single-stream, mass spectrometry (MS) methods. With the MPX TF software, researchers can increase throughput by as much as twofold. This is made possible by enabling the use of two parallel liquid chromatography streams. The ability to stagger chromatographic runs while collecting sample data

ELISA procedure to quantify human IgG, 9/13

The Binding Site now offers a specifically formulated and optimized ELISA procedure for the quantitation of intact human IgG from matrices containing non-human proteins. The assay is for clinical, biopharmaceutical, and medical researchers. The ELISA uses sheep polyclonal antibody, specific to the Fc and light chain regions of human IgG for capture and detection respectively, ensuring that only intact human IgG is quantified. The assay virtually eliminates any cross-reactivity to common laboratory species (for example, mouse, rat, primate) and to

TMB substrate-chromogen, 9/13

The Binding Site now offers a substrate-chromogen containing 3,3’,5,5’-tetramethylbenzidine (TMB). Designed for use as an integral component in peroxidase-based, colorimetric techniques, the TMB chromagen-substrate is for use in enzyme immunoassay test procedures. The TMB substrate-chromagen demonstrates decreased sensitivity to light when compared with other peroxidase chromogens and can be developed without any special precautions. Offered in a liquid-stable, ready-to-use format, the product displays exceptional shelf-life stability, lot-to-lot consistency, and specific performance characteristics. The TMB substrate-chromagen also permits for a safe

Human protein antibodies, 9/13

The Binding Site now offers a specialized line of anti-human serum protein antibodies. Through the use of a patented technique, which yields highly specific antibodies, all available products display a high degree of purity, shelf-life stability, and lot-to-lot consistency. The range of specialized antibodies includes those involved in blood coagulation, complement activation, acute-phase reactants, immunoglobulin response, and others. The antibodies can be conjugated to biotin, fluorescein, horseradish peroxidase, rhodamine, and others. The Binding Site, 800-633-4484

Water purification system, 9/13

Thermo Fisher Scientific has launched its Barnstead GenPure xCAD Plus water purification system, which has technology that allows simultaneous dispensing from three remote dispensers for exceptional flexibility and ease of use in shared laboratory environments. In addition to its advanced dispensing technology, the Barnstead GenPure xCAD Plus is easy to use and comes with leak detection, feed water monitoring, and all the consumables necessary to get started, allowing for simple ordering and setup. The system, now available in North America

Streamlined workflow for HPV test, 9/13

The FDA in June approved a workflow process for Roche Diagnostics’ Cobas HPV test that allows sample processing from the primary sample collection vial after it has been used for cytology (Pap) testing. The approval allows labs to load the same vial used for a ThinPrep Pap test directly onto Roche’s Cobas 4800 system for high-risk HPV and individual HPV 16 and 18 genotype testing. The new workflow option uses a special primary vial rack for the fully automated Cobas

Intelligent lab automation solution, 9/13

Roche’s Cobas 8100 automated workflow series is an advanced system designed to automate many routine tasks to help diagnostic laboratories increase efficiency, reduce expenses, and maximize patient safety. Through intelligent robotics, the Cobas 8100 series automatically prepares blood samples for immediate testing and post-analytical processing, providing high-speed processing of up to 1,100 samples per hour. The system offers dynamic and efficient sample transport options and great flexibility, allowing labs to automate routine and stat tests. Health care professionals benefit from

Vitamin D assay, 9/13

Tosoh Bioscience’s ST AIA-Pack 25-OH vitamin D assay is for use on most Tosoh AIA system analyzers. Vitamin D measurement is intended as an aid in the determination of vitamin D sufficiency. Using Tosoh’s unit-dose test-cup reagent technology, ST AIA-Pack 25-OH vitamin D has an assay time of about 40 minutes. Single, unitized test cups require no premixing, no premeasuring, and no onboard refrigeration. Dry-reagent format ensures 90-day calibration stability for minimal waste and cost-effective testing. Test cups are bar

Mobile cardiac diagnostic device, 9/13

Samsung Electronics presented details of the first peer-reviewed report of a pilot conducted with the National Health Service in Scotland, Borders General Hospital, the Scottish Ambulance Service, and the Scottish Centre for Telehealth and Telecare on the use of the company’s Labgeo IB10 portable blood analyzer to diagnose cardiac patients in transit to the hospital. Conducted in the sparsely populated Scottish Borders, the pilot sought to demonstrate the feasibility of diagnosing whether chest pain patients were suffering from a heart

Tuberculosis test, 9/13

Cepheid has received FDA market authorization for its Xpert MTB/RIF test, which provides results in about two hours. The review decision was based on the de novo 510(k) review process, which allows novel products without predicates to be downclassified and brought to market. Xpert MTB/RIF is for the rapid molecular detection of Mycobacterium tuberculosis complex (MTB-complex) DNA and, in specimens where MTB-complex DNA is detected, Xpert MTB/RIF also detects rifampin-resistant associated mutations of the rpoB gene. Designed for use on

MARKETPLACE

TRENDING